| scholarly article | Q13442814 |
| P2093 | author name string | Balaji Narasimhan | |
| Bret D Ulery | |||
| Michael J Wannemuehler | |||
| Bryan H Bellaire | |||
| Yashdeep Phanse | |||
| Avanti Sinha | |||
| P2860 | cites work | Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres | Q44842072 |
| Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. | Q45112818 | ||
| Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism | Q46848409 | ||
| Protein stability in the presence of polymer degradation products: consequences for controlled release formulations | Q46965558 | ||
| Intracellular delivery of core-shell fluorescent silica nanoparticles. | Q48014981 | ||
| The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres. | Q51036883 | ||
| Monocyte cholesterol homeostasis correlates with the presence of detergent resistant membrane microdomains | Q57351075 | ||
| Controlled delivery systems for proteins using polyanhydride microspheres | Q70684838 | ||
| Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity | Q73691187 | ||
| "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells | Q80212165 | ||
| The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages | Q28376212 | ||
| Trafficking of MHC class II molecules in the late secretory pathway | Q28612003 | ||
| Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation | Q30477557 | ||
| Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres | Q31033522 | ||
| Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery | Q32050099 | ||
| Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis | Q32078607 | ||
| Filtration of particulates in the human nose | Q32143630 | ||
| Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine | Q33290185 | ||
| Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy | Q33351322 | ||
| Opsonized virulent Brucella abortus replicates within nonacidic, endoplasmic reticulum-negative, LAMP-1-positive phagosomes in human monocytes | Q33788047 | ||
| Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. | Q34324135 | ||
| Biologically erodable microspheres as potential oral drug delivery systems | Q34423490 | ||
| Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems | Q34669081 | ||
| The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. | Q34801799 | ||
| Role of polyanhydrides as localized drug carriers. | Q36093677 | ||
| From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias | Q36270262 | ||
| Controlled release of polypeptides from polyanhydrides | Q36285043 | ||
| Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? | Q36659060 | ||
| Erosion of a new family of biodegradable polyanhydrides | Q36718117 | ||
| Regulation of raft-dependent endocytosis | Q36924377 | ||
| Vaccine adjuvants: current challenges and future approaches. | Q37244036 | ||
| The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent | Q38554132 | ||
| Gastrointestinal uptake of biodegradable microparticles: effect of particle size | Q38559899 | ||
| Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women | Q39540933 | ||
| Poly(ester-anhydride):poly(beta-amino ester) micro- and nanospheres: DNA encapsulation and cellular transfection | Q40370887 | ||
| A single-step immunization by sustained antigen release | Q41741707 | ||
| Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide) | Q42806631 | ||
| Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice | Q43665629 | ||
| Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides | Q44054861 | ||
| Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery | Q44130331 | ||
| Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma | Q44628773 | ||
| Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment | Q44816208 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 683-690 | |
| P577 | publication date | 2008-11-06 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Polymer chemistry influences monocytic uptake of polyanhydride nanospheres | |
| P478 | volume | 26 |
| Q90015581 | A single dose polyanhydride-based nanovaccine against paratuberculosis infection |
| Q41879397 | A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms |
| Q35887551 | Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen. |
| Q39329200 | Analyzing cellular internalization of nanoparticles and bacteria by multi-spectral imaging flow cytometry |
| Q58114671 | Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery |
| Q30426452 | Biomedical Applications of Biodegradable Polymers |
| Q42114702 | Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells |
| Q36957938 | Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery |
| Q64106279 | Design and synthesis of multivalent α-1,2-trimannose-linked bioerodible microparticles for applications in immune response studies of infection |
| Q33847904 | Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases |
| Q92044152 | Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation |
| Q41382022 | Effect of nanovaccine chemistry on humoral immune response kinetics and maturation |
| Q92421550 | Effect of the Hydrophilic-Hydrophobic Balance of Antigen-Loaded Peptide Nanofibers on Their Cellular Uptake, Cellular Toxicity, and Immune Stimulatory Properties |
| Q50317606 | Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf |
| Q46989472 | Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery |
| Q33740757 | Facile fabrication of polyanhydride/anesthetic nanoparticles with tunable release kinetics |
| Q38757220 | Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants. |
| Q42426154 | Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles |
| Q36317368 | High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles |
| Q38257645 | Nanoparticle based-immunotherapy against allergy. |
| Q61810273 | Nanoparticle-Based Vaccines Against Respiratory Viruses |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q98197151 | Nanotechnology-based antiviral therapeutics |
| Q38738244 | Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy. |
| Q38947130 | Poly(sebacic anhydride) nanocapsules as carriers: effects of preparation parameters on properties and release of doxorubicin |
| Q28550462 | Polyanhydride Nanoparticle Delivery Platform Dramatically Enhances Killing of Filarial Worms |
| Q57167166 | Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections |
| Q33710195 | Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses |
| Q37010485 | Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. |
| Q46571918 | Pulmonary biodistribution and cellular uptake of intranasally administered monodisperse particles |
| Q35619618 | Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants. |
| Q36598433 | Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation |
| Q37184111 | Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles. |
| Q51732398 | Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity. |
| Q34871862 | Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles |
| Q50928936 | Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. |
| Q90696345 | Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague |
| Q33981400 | The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging |
| Q50005095 | pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles. |
Search more.